SCHEMBL22319293

SCHEMBL22319293

O=C1CCCCCCCCCCOC1

nearest known ligand 0.50

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
TRIM24 O15164 2/20 0.50
TRIM33 Q9UPN9 2/20 0.50
CA1 P00915 1/20 0.40
CA9 Q16790 1/20 0.40
GAA P10253 1/20 0.31
LMNA P02545 1/20 0.30
TP53 P04637 1/20 0.30
TSHR P16473 1/20 0.30
NOS3 P29474 1/20 0.30
NOS1 P29475 1/20 0.30
NOS2 P35228 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7233911 1.00 ALDH1A1 (0.50) ALDH1A1TRIM24TRIM33CA1CA9
SCHEMBL28904122 1.00 ALDH1A1 (0.50) ALDH1A1TRIM24TRIM33CA1CA9
SCHEMBL29018328 1.00
SCHEMBL7560466 1.00 ALDH1A1 (0.50) ALDH1A1TRIM24TRIM33CA1CA9
SCHEMBL7560520 1.00 ALDH1A1 (0.50) ALDH1A1TRIM24TRIM33CA1CA9
SCHEMBL28670775 1.00 ALDH1A1 (0.50) ALDH1A1TRIM24TRIM33CA1CA9
SCHEMBL28416590 1.00 ALDH1A1 (0.50) ALDH1A1TRIM24TRIM33CA1CA9
SCHEMBL22319282 1.00 ALDH1A1 (0.50) ALDH1A1TRIM24TRIM33CA1CA9
SCHEMBL28658913 0.97 TRIM24 (0.55) ALDH1A1TRIM24TRIM33CA1CA9
SCHEMBL1821742 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240368001-A1 SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2024-11-07 US disclosed
US-11987506-B2 Salt recovery solution and processes of use thereof AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2024-05-21 US disclosed
US-11826704-B2 Thermo-responsive solution, and method of use therefor AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2023-11-28 US disclosed
US-20230257284-A1 SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2023-08-17 US disclosed
CN-116282078-A Salt recovery solution and method of using the same 阿克福特斯技术有限公司 2023-06-23 CN disclosed
US-20230043356-A1 A SOLVENT DRYING COMPOSITION AND PROCESSES THEREFOR AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2023-02-09 US disclosed
US-20220193608-A1 THERMO-RESPONSIVE SOLUTION, AND METHOD OF USE THEREFOR AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2022-06-23 US disclosed
US-20220185754-A1 AN ALCOHOL RECOVERY SOLUTION, AND METHOD OF USE THEREFOR AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2022-06-16 US disclosed
EP-3946712-A1 A SOLVENT DRYING COMPOSITION AND PROCESSES THERFOR Aquafortus Technologies Limited (NZ) 2022-02-09 EP disclosed
EP-3935035-A1 AN ALCOHOL RECOVERY SOLUTION, AND METHOD OF USE THEREFOR Aquafortus Technologies Limited (NZ) 2022-01-12 EP disclosed
US-11020706-B2 Thermo-responsive solution, and method of use therefor AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2021-06-01 US disclosed
WO-2020204733-A1 A SOLVENT DRYING COMPOSITION AND PROCESSES THERFOR AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2020-10-08 WO disclosed
US-20200308023-A1 SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2020-10-01 US disclosed
WO-2020185096-A1 AN ALCOHOL RECOVERY SOLUTION, AND METHOD OF USE THEREFOR AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2020-09-17 WO disclosed
EP-3691996-A2 A SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF Aquafortus Technologies Limited (NZ) 2020-08-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11020706-B2 Thermo-responsive solution, and method of use therefor AQP1, SLC39A11, THEM6 ALDH1A1 1602/4885TRIM24 3422/4885TRIM33 4450/4885
US-20230043356-A1 A SOLVENT DRYING COMPOSITION AND PROCESSES THEREFOR AQP1, AQP4, NOTUM ALDH1A1 3984/4885TRIM24 4597/4885TRIM33 4652/4885
US-20220185754-A1 AN ALCOHOL RECOVERY SOLUTION, AND METHOD OF USE THEREFOR ADH1C, ADH1A, ADH5 ALDH1A1 12/4885TRIM24 2377/4885TRIM33 3982/4885
US-20220193608-A1 THERMO-RESPONSIVE SOLUTION, AND METHOD OF USE THEREFOR AQP1, SLC39A11, THEM6 ALDH1A1 1602/4885TRIM24 3422/4885TRIM33 4450/4885
US-11826704-B2 Thermo-responsive solution, and method of use therefor AQP1, SLC39A11, THEM6 ALDH1A1 1602/4885TRIM24 3422/4885TRIM33 4450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.